会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • RNA virus vaccines and methods
    • RNA病毒疫苗和方法
    • US20070292453A1
    • 2007-12-20
    • US11639023
    • 2006-12-14
    • Robert FloydDirk Dittmer
    • Robert FloydDirk Dittmer
    • A61K39/00A61P43/00
    • A61K39/12A61K2039/5252C12N7/00C12N2770/24134C12N2770/24163Y02A50/394
    • The invention is a vaccine, and method of vaccination, against RNA viruses, including RNA viruses in the family Flaviviridae, which includes for example West Nile Virus, Yellow fever virus, Dengue fever virus, Hepatitis C virus, Pestiviruses, Bovine viral diarrhea virus, and Classical Swine fever virus, wherein the vaccine comprises the RNA virus or immunogenic portions thereof, which have been treated with and rendered non-pathogenic by a phenothiazine dye and visible light, the phenothiazine dyes, including, but not limited to, Methylene Blue (MB), Methylene Green, 1-methyl MB, 1,9-dimethyl MB, Azure A, Azure B, Azure C, thionine, and toluidine blue, or by squalene. The invention includes novel strains of WNV for use in producing a vaccine, and novel primers and their use in recognizing and amplifying all of or portions of the WNV genome for diagnosing WNV infections, for quality control of the vaccine, or for identifying the presence of WNV in blood or blood products.
    • 本发明是一种针对RNA病毒的疫苗和疫苗接种方法,包括黄病毒科中的RNA病毒,其包括例如西尼罗河病毒,黄热病毒,登革热病毒,丙型肝炎病毒,瘟病毒,牛病毒性腹泻病毒, 和经典猪瘟病毒,其中疫苗包括已经用吩噻嗪染料和可见光处理并由其引起非致病性的RNA病毒或其免疫原性部分,吩噻嗪染料,包括但不限于亚甲蓝( MB),亚甲基绿,1-甲基MB,1,9-二甲基MB,Azure A,Azure B,Azure C,硫堇和甲苯胺蓝,或角鲨烯。 本发明包括用于生产疫苗的新型WNV菌株,以及新型引物及其用于识别和扩增WNV基因组的全部或部分用于诊断WNV感染,用于质量控制疫苗或用于鉴定 血液或血液制品中的WNV。
    • 7. 发明申请
    • Spin trapping pharmaceutical compositions and methods for use thereof
    • 旋转捕获药物组合物及其使用方法
    • US20050107366A1
    • 2005-05-19
    • US10937804
    • 2004-09-10
    • John CarneyRobert Floyd
    • John CarneyRobert Floyd
    • A61K31/13A61K31/135A61K31/15A61K31/165A61K31/167A61K31/195A61K31/40A61K31/4172A61K31/44A61K31/445A61K31/5415C07C291/02
    • C07C291/02A61K31/13A61K31/135A61K31/15A61K31/165A61K31/167A61K31/195A61K31/40A61K31/4172A61K31/44A61K31/445A61K31/5415
    • Spin trapping compositions in general have now been discovered to be effective in treating a variety of disorders, including disorders such as those arising from ischemia, infection, inflammation, exposure to radiation or cytotoxic compounds, not just of the central and peripheral nervous systems but of peripheral organ disease having a wide variety of etiologies. In the preferred embodiment, the compositions for treating tissue damage from ischemia contain PBN, or active derivatives thereof, in a suitable pharmaceutical carrier for intravenous oral, topical, or nasal/pulmonary administration. Other preferred spin-trapping agents include 5,5-dimethyl pyrrolidine N-oxide (DMPO), α-(4-pyridyl-1-oxide)-N-tert-butylnitrone (POBN), and (TEMPO) and spin-trapping derivatives, conjugates with drugs or targeting molecules, dimmers and cyclodextran polymers of PBN. Many different disorders can be treated using these compounds, including diseases or disorders of the central and peripheral nervous systems, and disorders arising from ischemia, infection, inflammation, oxidation from exposure to radiation or cytotoxic compounds, as well as due to naturally occurring processes such as aging.
    • 现在已经发现旋转捕获组合物现在已被发现有效地治疗各种疾病,包括诸如由局部缺血,感染,炎症,暴露于辐射或细胞毒性化合物引起的疾病,不仅仅是中枢和周围神经系统,而是 外周器官疾病具有多种病因。 在优选的实施方案中,用于治疗来自局部缺血的组织损伤的组合物在用于静脉内口服,局部或鼻/肺部施用的合适的药物载体中含有PBN或其活性衍生物。 其他优选的自旋捕获剂包括5,5-二甲基吡咯烷N-氧化物(DMPO),α-(4-吡啶基-1-氧化物)-N-叔丁基硝酮(POBN)和(TEMPO)和自旋捕获衍生物 与PBN的药物或靶向分子,二聚体和环糊精聚合物缀合。 可以使用这些化合物治疗许多不同的病症,包括中枢和周围神经系统的疾病或病症,以及由缺血,感染,炎症,暴露于辐射或细胞毒性化合物的氧化引起的疾病,以及由于天然存在的过程 作为老化。